Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain
2010
Introduction
This pooled analysis of data from three phase 3 studies in patients with chronic osteoarthritis knee or low back pain evaluated the efficacy and tolerability of tapentadol prolonged release (PR; 100–250 mg twice daily) compared with placebo and oxycodone hydrochloride (HCl) controlled release (CR; 20–50 mg twice daily).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
161
Citations
NaN
KQI